Showing results (671-680 of 897) with videos related to
Sort By:
Pageof 90
Journal of Breast Cancer|December 8, 2022
Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene AssayJun-Hee Lee, Jai Min Ryu, Jee Hyun Ahn, et al.Oncology Reports|October 4, 2011
Effect of berberine on p53 expression by TPA in breast cancer cellsSangmin Kim, Jeonghun Han, Nam-Young Kim, et al.Biochemical and Biophysical Research Communications|August 31, 2010
Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancerHee June Choi, Ji Min Lee, Hyunkyung Kim, et al.Oncotarget|November 22, 2017
Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapyJi-Yeon Kim, Donghyun Park, Dae-Soon Son, et al.Journal of Breast Cancer|April 3, 2015
Sentinel lymph node biopsy alone after neoadjuvant chemotherapy in patients with initial cytology-proven axillary node metastasisJi Young Kim, Min Kuk Kim, Jeong Eon Lee, et al.Molecular Cancer Therapeutics|November 13, 2012
Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancerHyun-Jin Nam, Seock-Ah Im, Do-Youn Oh, et al.Cancers|November 25, 2023
The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched AnalysisKangpyo Kim, Won Park, Haeyoung Kim, et al.Breast Cancer Research and Treatment|September 22, 2018
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?Se Kyung Lee, Seok Won Kim, Jong-Han Yu, et al.Experimental & Molecular Medicine|March 12, 2005
Genetic polymorphism of CYP17 and breast cancer risk in Korean womenMyung-Hee Shin, Kyoung-Mu Lee, Jung-Hyun Yang, et al.Journal of Breast Cancer|January 30, 2026
A Practical Immunohistochemistry-Based Model for Predicting Pathologic Complete Response in Estrogen Receptor-Strong Positive and HER2-Negative Breast Cancer Running title: IHC-Based Prediction Model of pCR in ER-Positive HER2-Negative Breast CancerSu Min Lee, Jeong Eon Lee, Seok Jin Nam, et al.Pageof 90